The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.If you have any queries on this, then please contact Steve Boldy, the Chief Executive Officer of the Company (responsible for arranging release of this announcement).
8 October 2019
Lansdowne Oil & Gas plc
("Lansdowne" or the "Company")
Update on Brandon Hill Capital Shareholding
Lansdowne Oil & Gas plc (AIM: LOGP), the North Celtic Sea focused, oil and gas company, today announces that it has been advised by Oliver Stansfield that last week he increased his beneficial interest in the Company by 3,000,000 ordinary shares, to a revised holding of 20,000,000 ordinary shares, representing 3.01% of the outstanding share capital of the Company.
Oliver Stansfield is the CEO of Brandon Hill Capital Limited, the Company's broker and major shareholder, which has a direct holding of a further 93,493,593 ordinary shares, representing 14.05% of the outstanding issued share capital. Other Brandon Hill directors hold a beneficial interest in an additional 26,002,051 ordinary shares, representing 3.91% of the Company.
Consequently, the revised combined interest of the Brandon Hill parties is now 139,495,644 shares, representing 20.97% of the Company.
For further information please contact:
Lansdowne Oil & Gas plc
+353 1 963 1760
SP Angel Corporate Finance LLP
+44 (0) 20 3470 0470
Nominated Adviser and Joint Broker
Brandon Hill Capital
+44 (0) 20 3463 5061
Notes to editors:
Lansdowne Oil & Gas (LOGP.LN) is a North Celtic Sea focused, oil and gas exploration and appraisal company quoted on the AIM market and head quartered in Dublin.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...